The regulatory environment surrounding OTC derivatives has drastically changed in recent years.  The Dodd-Frank Act in the U.S., EMIR in the EU and FIEA in Japan interact and overlap with one another, creating a complex regulatory framework. 

Seiji Matsuzoe will give an overview of the regulatory framework relating to OTC derivatives from a Japanese bank and financial institution perspective, including:

• overview of Dodd-Frank Act and EMIR
• proposed or expected development in Japanese OTC derivative regulations
• comparison of Dodd-Frank Act, EMIR and FIEA

Seiji Matsuzoe is a member of Banking/Capital Market team in White & Case Tokyo.  He practices in the areas of structured finance including CDOs, credit-linked loans, warrant-backed loans, and wide range of securitization transactions, derivatives, debt capital markets, acquisition finance and general banking transactions. Seiji has a wealth of experience in the global market and has worked for a wide range of international investment banks and Japanese financial institutions.  He was a member of the FSA’s Committee on OTC Derivatives Regulations.